JOURNAL ARTICLE
Add like
Add dislike
Add to saved papers

Perioperative complication rates of primary and repeat hysteroscopic endometrial ablations.

STUDY OBJECTIVE: To determine perioperative complication rates at primary and repeat endometrial ablations.

DESIGN: Prospective cohort study (Canadian Task Force classification II-2).

SETTING: Tertiary care teaching hospital.

PATIENTS: Seventy-five women who underwent a repeat ablation and 800 who had a primary ablation by the same surgeon (GAV) between 1990 and 2000 for a diagnosis of menorrhagia and/or dysmenorrhea.

INTERVENTIONS: Hysteroscopic ablation involving coagulation or resection of endometrium, and second ablation after failure of the first.

MEASUREMENTS AND MAIN RESULTS: Serious perioperative complications were uterine perforation, hemorrhage, excess fluid absorption, and genital tract burns. They occurred in 9.3% of repeat ablations compared with 2.05% of primary ablations (p = 0.006).

CONCLUSION: Repeat endometrial ablation has a significantly higher rate of perioperative complications than primary ablation.

Full text links

For the best experience, use the Read mobile app

Group 7SearchHeart failure treatmentPapersTopicsCollectionsEffects of Sodium-Glucose Cotransporter 2 Inhibitors for the Treatment of Patients With Heart Failure Importance: Only 1 class of glucose-lowering agents-sodium-glucose cotransporter 2 (SGLT2) inhibitors-has been reported to decrease the risk of cardiovascular events primarily by reducingSeptember 1, 2017: JAMA CardiologyAssociations of albuminuria in patients with chronic heart failure: findings in the ALiskiren Observation of heart Failure Treatment study.CONCLUSIONS: Increased UACR is common in patients with heart failure, including non-diabetics. Urinary albumin creatininineJul, 2011: European Journal of Heart FailureRandomized Controlled TrialEffects of Liraglutide on Clinical Stability Among Patients With Advanced Heart Failure and Reduced Ejection Fraction: A Randomized Clinical Trial.Review

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

Read by QxMD is copyright © 2021 QxMD Software Inc. All rights reserved. By using this service, you agree to our terms of use and privacy policy.

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app